Cancer stem cells, stemness markers and selected drug targeting: metastatic colorectal cancer and cyclooxygenase-2/prostaglandin E2 connection to WNT as a model system

Abstract

Few studies have reported on the analyses of drugs targeting enriched populations of cancer stem cells (CSCs) as a means for identifying potent anti-CSC agents. This review evaluates recent information on the identification and functions of specific CSC surface markers, with particular emphasis on colorectal cancers and the screening of drugs to eliminate such cells. Many of these CSC markers are found commonly expressed on CSCs from different cancer types as well as embryonic stem cells. These markers are often related to hypoxic activation of the WNT/b-catenin pathway, cyclooxygenase-2/prostaglandin E signalling and their relationship to LGR5. By effectively using drugs that inhibit these pathways to kill the CSC population, or otherwise forcing them out of dormancy into active cell division, cancers should become more susceptible to chemotherapy. Such combinational therapies targeting both CSCs and proliferating tumor cells should greatly improve upon the current basis for treatment.

Keywords

Cancer stem cells / colorectal cancer / markers / selective drug targeting

References

[1] Kozovska Z,Kucerova L.Colon cancer: cancer stem cells markers, drug resistance and treatment..Biomed Pharmacother2014;68:911-6

[2] Shimokawa M,Nishikori S,Takano A.Visualization and targeting of LGR5+ human colon cancer stem cells..Nature2017;545:187-92

[3] Cortina C,Stork D,Sevillano M.A genome editing approach to study cancer stem cells in human tumors..EMBO Mol Med2017;9:869-79 PMCID:PMC5494503

[4] de Sousa e Melo F,Harnoss JM,Hoeck JD.A distinct role for Lgr5(+) stem cells in primary and metastatic colon cancer..Nature2017;543:676-80

[5] Todaro M,Medema JP.Colon cancer stem cells: promise of targeted therapy..Gastroenterology2010;138:2151-62

[6] Rahman M,Vedam-Mai V,Abd-El-Barr M.The cancer stem cell hypothesis: failures and pitfalls..Neurosurgery2011;68:531-45

[7] Jordan CT,Noble M.Cancer stem cells..N Engl J Med2006;355:1253-61

[8] Jones RJ.Cancer stem cells: from bench to bedside..Biol Blood Marrow Transplant2007;13:47-52 PMCID:PMC1858645

[9] Kim WT.Cancer stem cell surface markers on normal stem cells..BMB Rep2017;50:285-98 PMCID:PMC5498139

[10] Cherciu I,Pirici D,Saftoiu A.Stem cells, colorectal cancer and cancer stem cell markers correlations..Curr Health Sci J2014;40:153-61 PMCID:PMC4340434

[11] Vermeulen L,de Sousa Mello F,Kemper K.Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity..Proc Natl Acad Sci U S A2008;105:13427-32 PMCID:PMC2533206

[12] Reya T,Clarke MF.Stem cells, cancer, and cancer stem cells..Nature2001;414:105-11

[13] Dirks PB.Cancer: stem cells and brain tumours..Nature2006;444:687-8

[14] Richard V,Santhosh Kumar TR.Side population cells as prototype of chemoresistant, tumor-initiating cells..Biomed Res Int2013;2013:517237 PMCID:PMC3834974

[15] Tomita H,Tanaka T.Aldehyde dehydrogenase 1A1 in stem cells and cancer..Oncotarget2016;7:11018-32 PMCID:PMC4905455

[16] Kelly PN,Adams JM,Strasser A.Tumor growth need not be driven by rare cancer stem cells..Science2007;317:337

[17] Kalluri R.The basics of epithelial-mesenchymal transition..J Clin Invest2009;119:1420-8 PMCID:PMC2689101

[18] Pantel K.Circulating tumour cells in cancer patients: challenges and perspectives..Trends Mol Med2010;16:398-406

[19] Meacham CE.Tumour heterogeneity and cancer cell plasticity..Nature2013;501:328-37 PMCID:PMC4521623

[20] Poli V,Zippo A.Tumorigenic cell reprogramming and cancer plasticity: interplay between signaling, microenvironment, and epigenetics..Stem Cells Int2018;2018:4598195 PMCID:PMC5954911

[21] Batlle E.Cancer stem cells revisited..Nat Med2017;23:1124-34

[22] Policastro LL,Notcovich C,Podhajcer OL.The tumor microenvironment: characterization, redox considerations, and novel approaches for reactive oxygen species-targeted gene therapy..Antioxid Redox Signal2013;19:854-95

[23] Ralph SJ,Moreno-Sánchez R,Pritchard R.NSAID celecoxib: a potent mitochondrial pro-oxidant cytotoxic agent sensitizing metastatic cancers and cancer stem cells to chemotherapy..J Cancer Metastasis Treat2018;4:49

[24] Shao Y,Zheng X,Xu K.Colorectal cancer-derived small extracellular vesicles establish an inflammatory premetastatic niche in liver metastasis..Carcinogenesis2018;39:1368-79

[25] Blassl C,Webers A,Fehm T.Gene expression profiling of single circulating tumor cells in ovarian cancer - establishment of a multi-marker gene panel..Mol Oncol2016;10:1030-42 PMCID:PMC5423187

[26] Francart ME,Vanwynsberghe AM,Bourcy M.Epithelial-mesenchymal plasticity and circulating tumor cells: travel companions to metastases..Dev Dyn2018;247:432-50

[27] Alix-Panabieres C,Pantel K.Epithelial-mesenchymal plasticity in circulating tumor cells..J Mol Med (Berl)2017;95:133-42

[28] Grillet F,Villeronce O,Lagerqvist EL.Circulating tumour cells from patients with colorectal cancer have cancer stem cell hallmarks in ex vivo culture..Gut2017;66:1802-10 PMCID:PMC5595103

[29] Zhu P.Cancer stem cells and tumorigenesis..Biophys Rep2018;4:178-88 PMCID:PMC6153490

[30] Katoh M.Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review)..Int J Oncol2017;51:1357-69 PMCID:PMC5642388

[31] Krishnamurthy N.Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors..Cancer Treat Rev2018;62:50-60 PMCID:PMC5745276

[32] Sawa M,Yamada T.Targeting the Wnt signaling pathway in colorectal cancer..Expert Opin Ther Targets2016;20:419-29

[33] Masuda M,Ohbayashi N,Mimata A.TNIK inhibition abrogates colorectal cancer stemness..Nat Commun2016;7:12586 PMCID:PMC5007443

[34] Begicevic RR.ABC Transporters in cancer stem cells: beyond chemoresistance..Int J Mol Sci2017;18:2362 PMCID:PMC5713331

[35] Zhang G,Luo W,Wu J.Expression of potential cancer stem cell marker ABCG2 is Associated with malignant behaviors of hepatocellular carcinoma..Gastroenterol Res Pract2013;2013:782581 PMCID:PMC3806359

[36] Liu HG,You J,Huang KT.Expression of ABCG2 and its significance in colorectal cancer..Asian Pac J Cancer Prev2010;11:845-8

[37] Wang X,Liang Y,Wang Z.Membranous ABCG2 expression in colorectal cancer independently correlates with shortened patient survival..Cancer Biomark2013;13:81-8

[38] Ma S,Hu L,Wo JY.Identification and characterization of tumorigenic liver cancer stem/progenitor cells..Gastroenterology2007;132:2542-56

[39] Zhao W,Zhang F,Ma L.Embryonic stem cell markers..Molecules2012;17:6196-236 PMCID:PMC6268870

[40] Hang D,Ning T,Hou DL.Prognostic value of the stem cell markers CD133 and ABCG2 expression in esophageal squamous cell carcinoma..Dis Esophagus2012;25:638-44

[41] Barron GA,Woods JA.Differential sensitivity in cell lines to photodynamic therapy in combination with ABCG2 inhibition..J Photochem Photobiol B2013;126:87-96

[42] Dvorak P,Soucek P.ABC gene expression profiles have clinical importance and possibly form a new hallmark of cancer..Tumour Biol2017;39:1010428317699800

[43] Sukowati CH,Pascut D,Torre G.Gene and functional up-regulation of the BCRP/ABCG2 transporter in hepatocellular carcinoma..BMC Gastroenterol2012;12:160 PMCID:PMC3538657

[44] Porro A,Diolaiti D,Henderson M.Direct and coordinate regulation of ATP-binding cassette transporter genes by Myc factors generates specific transcription signatures that significantly affect the chemoresistance phenotype of cancer cells..J Biol Chem2010;285:19532-43 PMCID:PMC2885232

[45] Chikazawa N,Tasaka T,Tanaka M.Inhibition of Wnt signaling pathway decreases chemotherapy-resistant side-population colon cancer cells..Anticancer Res2010;30:2041-8

[46] Chang YW,Hsiao M,Lin WH.Diverse targets of beta-catenin during the epithelial-mesenchymal transition define cancer stem cells and predict disease relapse..Cancer Res2015;75:3398-410

[47] Ding XW,Jiang CP.ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy..Life Sci2010;86:631-7

[48] Alowaidi F,Alqurashi N,Ivanovski S.Assessing stemness and proliferation properties of the newly established colon cancer ‘stem’ cell line, CSC480 and novel approaches to identify dormant cancer cells..Oncol Rep2018;39:2881-91

[49] Weigmann A,Hellwig A.Prominin, a novel microvilli-specific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells..Proc Natl Acad Sci U S A1997;94:12425-30 PMCID:PMC24979

[50] Glumac PM.The role of CD133 in cancer: a concise review..Clin Transl Med2018;7:18 PMCID:PMC6035906

[51] Singh SK,Terasaki M,Hawkins C.Identification of a cancer stem cell in human brain tumors..Cancer Res2003;63:5821-8

[52] Vaiopoulos AG,Koutsilieris M.Colorectal cancer stem cells..Stem Cells2012;30:363-71

[53] O’Brien CA,Gallinger S.A human colon cancer cell capable of initiating tumour growth in immunodeficient mice..Nature2007;445:106-10

[54] Eramo A,Sette G,Biffoni M.Identification and expansion of the tumorigenic lung cancer stem cell population..Cell Death Differ2008;15:504-14

[55] Collins AT,Hyde C,Maitland NJ.Prospective identification of tumorigenic prostate cancer stem cells..Cancer Res2005;65:10946-51

[56] Chen H,Dong L,Yang J.CD133/prominin-1-mediated autophagy and glucose uptake beneficial for hepatoma cell survival..PLoS One2013;8:e56878 PMCID:PMC3577658

[57] Lin SH,Ming X,Fu L.Regulatory role of hexosamine biosynthetic pathway on hepatic cancer stem cell marker CD133 under low glucose conditions..Sci Rep2016;6:21184 PMCID:PMC4754761

[58] Du L,He L,Ni B.CD44 is of functional importance for colorectal cancer stem cells..Clin Cancer Res2008;14:6751-60

[59] Shmelkov SV,Hooper AT,Kushner J.CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors..J Clin Invest2008;118:2111-20 PMCID:PMC2391278

[60] Misra S,Berger FG,Ghatak S.Hyaluronan, CD44, and cyclooxygenase-2 in colon cancer..Connect Tissue Res2008;49:219-24

[61] Ghatak S,Toole BP.Hyaluronan constitutively regulates ErbB2 phosphorylation and signaling complex formation in carcinoma cells..J Biol Chem2005;280:8875-83

[62] Misra S,Markwald RR.Interactions between hyaluronan and its receptors (CD44, RHAMM) regulate the activities of inflammation and cancer..Front Immunol2015;6:201 PMCID:PMC4422082

[63] Sheridan C,Fuchs RK,Bhat-Nakshatri P.CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis..Breast Cancer Res2006;8:R59 PMCID:PMC1779499

[64] Omara-Opyene AL,Shah GV.Prostate cancer invasion is influenced more by expression of a CD44 isoform including variant 9 than by Muc18..Lab Invest2004;84:894-907

[65] Li C,Dalerba P,Zhang L.Identification of pancreatic cancer stem cells..Cancer Res2007;67:1030-7

[66] Cortes-Dericks L,Boesch R,Karoubi G.Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDH(high)CD44(+) phenotype and sphere-forming capacity..BMC Cancer2014;14:304 PMCID:PMC4021184

[67] Ohno Y,Miyake S,Fudesaka S.Differential regulation of the sphere formation and maintenance of cancer-initiating cells of malignant mesothelioma via CD44 and ALK4 signaling pathways..Oncogene2018;37:6357-67 PMCID:PMC6283855

[68] Paradis V,Loric S,Ba N.De novo expression of CD44 in prostate carcinoma is correlated with systemic dissemination of prostate cancer..J Clin Pathol1998;51:798-802 PMCID:PMC500969

[69] Al-Hajj M,Benito-Hernandez A,Clarke MF.Prospective identification of tumorigenic breast cancer cells..Proc Natl Acad Sci U S A2003;100:3983-8 PMCID:PMC153034

[70] Dontu G,Foley JM,Clarke MF.In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells..Genes Dev2003;17:1253-70 PMCID:PMC196056

[71] Patrawala L,Schneider-Broussard R,Bhatia B.Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells..Oncogene2006;25:1696-708

[72] Hurt EM,Klarmann GJ,Farrar WL.CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis..Br J Cancer2008;98:756-65 PMCID:PMC2259168

[73] Dalerba P,Park IK,Wang X.Phenotypic characterization of human colorectal cancer stem cells..Proc Natl Acad Sci U S A2007;104:10158-63 PMCID:PMC1891215

[74] Todaro M,Catalano V,Iovino F.CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis..Cell Stem Cell2014;14:342-56

[75] Prince ME,Kaczorowski A,Kaplan MJ.Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma..Proc Natl Acad Sci U S A2007;104:973-8 PMCID:PMC1783424

[76] Schreiber CL.Molecular imaging of aminopeptidase N in cancer and angiogenesis..Contrast Media Mol Imaging2018;2018:5315172 PMCID:PMC6036854

[77] Castelli G,Testa U.Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells..Cancers (Basel)2017;9:pii: E127 PMCID:PMC5615342

[78] Nakayama M,Akiba J,Koura K.Side population cell fractions from hepatocellular carcinoma cell lines increased with tumor dedifferentiation, but lack characteristic features of cancer stem cells..J Gastroenterol Hepatol2014;29:1092-101

[79] Haraguchi N,Mimori K,Ohkuma M.CD13 is a therapeutic target in human liver cancer stem cells..J Clin Invest2010;120:3326-39 PMCID:PMC2929722

[80] Yamashita M,Eguchi H,Yamada D.A CD13 inhibitor, ubenimex, synergistically enhances the effects of anticancer drugs in hepatocellular carcinoma..Int J Oncol2016;49:89-98 PMCID:PMC4902077

[81] Yamanaka C,Eguchi H,Gotoh K.Clinical significance of CD13 and epithelial mesenchymal transition (EMT) markers in hepatocellular carcinoma..Jpn J Clin Oncol2018;48:52-60

[82] Zheng YB,Liu XJ,Zhen YS.A CD13-targeting peptide integrated protein inhibits human liver cancer growth by killing cancer stem cells and suppressing angiogenesis..Mol Carcinog2017;56:1395-404

[83] Hashida H,Kanai M,Kondo K.Aminopeptidase N is involved in cell motility and angiogenesis: its clinical significance in human colon cancer..Gastroenterology2002;122:376-86

[84] Al-Kharusi MR,Greenhough A,Emery ED.LGR5 promotes survival in human colorectal adenoma cells and is upregulated by PGE2: implications for targeting adenoma stem cells with NSAIDs..Carcinogenesis2013;34:1150-7 PMCID:PMC3643418

[85] Lebensohn AM.R-spondins can potentiate WNT signaling without LGR..Elife2018;7:e33126 PMCID:PMC5800842

[86] Park S,Yu W,Carmon KS.Differential activities and mechanisms of the four R-spondins in potentiating Wnt/beta-catenin signaling..J Biol Chem2018;293:9759-69 PMCID:PMC6016459

[87] Zhou X,Wang D,Talmon G.R-Spondin1/LGR5 Activates TGFbeta signaling and suppresses colon cancer metastasis..Cancer Res2017;77:6589-602 PMCID:PMC5898809

[88] Barker N,Kuipers J,van den Born M.Identification of stem cells in small intestine and colon by marker gene Lgr5..Nature2007;449:1003-7

[89] Garcia MI,Lefort A,Strollo S.LGR5 deficiency deregulates Wnt signaling and leads to precocious Paneth cell differentiation in the fetal intestine..Dev Biol2009;331:58-67

[90] Leung C,Barker N.Recent advances in Lgr5(+) stem cell research..Trends Cell Biol2018;28:380-91

[91] Wu C,Gao F,Guo Y.Lgr5 expression as stem cell marker in human gastric gland and its relatedness with other putative cancer stem cell markers..Gene2013;525:18-25

[92] Buczacki SJ,Nicholson AM,Vermeulen L.Intestinal label-retaining cells are secretory precursors expressing Lgr5..Nature2013;495:65-9

[93] Barker N,Jaks V,Snippert H.Very long-term self-renewal of small intestine, colon, and hair follicles from cycling Lgr5+ve stem cells..Cold Spring Harb Symp Quant Biol2008;73:351-6

[94] Haegebarth A.Wnt signaling, lgr5, and stem cells in the intestine and skin..Am J Pathol2009;174:715-21 PMCID:PMC2665733

[95] Song SJ,Wang C,Yan M.LGR5/GPR49 is implicated in motor neuron specification in nervous system..Neurosci Lett2015;584:135-40

[96] Qi C,Chen X,Wang J.Hypoxia stimulates neural stem cell proliferation by increasing HIF1alpha expression and activating Wnt/beta-catenin signaling..Cell Mol Biol (Noisy-le-grand)2017;63:12-9 PMCID:PMC5614483

[97] Nakata S,Bageritz J,Becker N.LGR5 is a marker of poor prognosis in glioblastoma and is required for survival of brain cancer stem-like cells..Brain Pathol2013;23:60-72

[98] Jang BG,Chang WY,Kim WH.Expression profile of LGR5 and Its prognostic significance in colorectal cancer progression..Am J Pathol2018;188:2236-50

[99] Walker F,Odorizzi A.LGR5 is a negative regulator of tumourigenicity, antagonizes Wnt signalling and regulates cell adhesion in colorectal cancer cell lines..PLoS One2011;6:e22733 PMCID:PMC3145754

[100] Morgan RG,Williams AC.Targeting LGR5 in colorectal cancer: therapeutic gold or too plastic?.Br J Cancer2018;118:1410-8 PMCID:PMC5988707

[101] Leng Z,Chen J,Xu J.Lgr5+CD44+EpCAM+ strictly defines cancer stem cells in human colorectal cancer..Cell Physiol Biochem2018;46:860-72

[102] Medema JP.Targeting the colorectal cancer stem cell..N Engl J Med2017;377:888-90

[103] Litvinov SV,Bakker HAM,Warnaar SO.Ep-Cam: a human epithelial antigen is a homophilic cell-cell adhesion molecule..J Cell Biol1994;125:437-46 PMCID:PMC2120036

[104] Anderson R,Heasman J.Expression of the homophilic adhesion molecule, Ep-CAM, in the mammalian germ line..J Reprod Fertil1999;116:379-84

[105] van der Gun BT,Ruiters MH,McLaughlin PM.EpCAM in carcinogenesis: the good, the bad or the ugly..Carcinogenesis2010;31:1913-21

[106] Boesch M,Seeber A.Concise Review: Aggressive colorectal cancer: role of epithelial cell adhesion molecule in cancer stem cells and epithelial-to-mesenchymal transition..Stem Cells Transl Med2018;7:495-501 PMCID:PMC5980125

[107] Huang L,Yang F,Zhu Z.Functions of EpCAM in physiological processes and diseases (Review)..Int J Mol Med2018;42:1771-85 PMCID:PMC6108866

[108] Kempers MJ,Ockeloen CW,Hutter P.Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study..Lancet Oncol2011;12:49-55 PMCID:PMC3670774

[109] Basak S,Eck S,Maul G.Colorectal carcinoma invasion inhibition by CO17-1A/GA733 antigen and its murine homologue..J Natl Cancer Inst1998;90:691-7

[110] Winter MJ,Mertens AE,Briaire-de Bruijn IH.Expression of Ep-CAM shifts the state of cadherin-mediated adhesions from strong to weak..Exp Cell Res2003;285:50-8

[111] Maetzel D,Mack B,Went P.Nuclear signalling by tumour-associated antigen EpCAM..Nat Cell Biol2009;11:162-71

[112] Schmidt M,Sebastian M,Marschner N.Phase IB study of the EpCAM antibody adecatumumab combined with docetaxel in patients with EpCAM-positive relapsed or refractory advanced-stage breast cancer..Ann Oncol2012;23:2306-13

[113] Gastl G,Obrist P,Mikuz G.Ep-CAM overexpression in breast cancer as a predictor of survival..Lancet2000;356:1981-2

[114] Spizzo G,Dirnhofer S,Simon R.High Ep-CAM expression is associated with poor prognosis in node-positive breast cancer..Breast Cancer Res Treat2004;86:207-13

[115] Bokemeyer C.Catumaxomab--trifunctional anti-EpCAM antibody used to treat malignant ascites..Expert Opin Biol Ther2010;10:1259-69

[116] Baeuerle PA.EpCAM (CD326) finding its role in cancer..Br J Cancer2007;96:417-23 PMCID:PMC2360029

[117] Aktas B,Fehm T,Kimmig R.Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients..Breast Cancer Res2009;11:R46 PMCID:PMC2750105

[118] Balzar M,de Boer CJ.The biology of the 17-1A antigen (Ep-CAM)..J Mol Med (Berl)1999;77:699-712

[119] Trzpis M,van Goor H,van Dam GM.Expression of EpCAM is up-regulated during regeneration of renal epithelia..J Pathol2008;216:201-8

[120] Imai T,Oizumi S,Yamaguchi K.CD271 defines a stem cell-like population in hypopharyngeal cancer..PLoS One2013;8:e62002 PMCID:PMC3633921

[121] Boiko AD,van de Rijn M,Johnson DL.Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271..Nature2010;466:133-7 PMCID:PMC2898751

[122] Tomellini E,Polakowska R.Role of p75 neurotrophin receptor in stem cell biology: more than just a marker..Cell Mol Life Sci2014;71:2467-81

[123] Watson JT,Wu J,Thorpe M.CD271 as a marker for mesenchymal stem cells in bone marrow versus umbilical cord blood..Cells Tissues Organs2013;197:496-504

[124] Alvarez-Viejo M,Otero-Hernandez J.CD271 as a marker to identify mesenchymal stem cells from diverse sources before culture..World J Stem Cells2015;7:470-6 PMCID:PMC4369502

[125] Redmer T,Behrens D,Przybilla D.The nerve growth factor receptor CD271 is crucial to maintain tumorigenicity and stem-like properties of melanoma cells..PLoS One2014;9:e92596 PMCID:PMC4010406

[126] Li S,Chen X,Li J.Epigenetic regulation of CD271, a potential cancer stem cell marker associated with chemoresistance and metastatic capacity..Oncol Rep2015;33:425-32 PMCID:PMC4440220

[127] Huang SD,Liu XH,Bai CG.Self-renewal and chemotherapy resistance of p75NTR positive cells in esophageal squamous cell carcinomas..BMC Cancer2009;9:9 PMCID:PMC2637890

[128] Kojima H,Yamaguchi T,Shimada Y.Enhanced cancer stem cell properties of a mitotically quiescent subpopulation of p75NTR-positive cells in esophageal squamous cell carcinoma..Int J Oncol2017;51:49-62 PMCID:PMC5467780

[129] Okumura T,Watanabe T,Shimada Y.Flow cytometric detection of circulating tumor cells using a candidate stem cell marker, p75 neurotrophin receptor (p75NTR)..Methods Mol Biol2017;1634:211-7

[130] Chung MK,Lee JK,Murillo-Sauca O.CD271 Confers an invasive and metastatic phenotype of head and neck squamous cell carcinoma through the upregulation of slug..Clin Cancer Res2018;24:674-83

[131] Furuta J,Harada K.CD271 on melanoma cell is an IFN-gamma-inducible immunosuppressive factor that mediates downregulation of melanoma antigens..J Invest Dermatol2014;134:1369-77

[132] Redmer T,Klinger B,Welte Y.The role of the cancer stem cell marker CD271 in DNA damage response and drug resistance of melanoma cells..Oncogenesis2017;6:e291 PMCID:PMC5294251

[133] Radke J,Redmer T.CD271 determines migratory properties of melanoma cells..Sci Rep2017;7:9834 PMCID:PMC5574914

[134] Civenni G,Kobert N,Zipser M.Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth..Cancer Res2011;71:3098-109

[135] Guo R,Goddard L,Chen J.Increased expression of melanoma stem cell marker CD271 in metastatic melanoma to the brain..Int J Clin Exp Pathol2014;7:8947-51 PMCID:PMC4313973

[136] Redmer T.Deciphering mechanisms of brain metastasis in melanoma - the gist of the matter..Mol Cancer2018;17:106 PMCID:PMC6064184

[137] Csermely P,Korcsmaros T,Perez-Lopez AR.Cancer stem cells display extremely large evolvability: alternating plastic and rigid networks as a potential mechanism: network models, novel therapeutic target strategies, and the contributions of hypoxia, inflammation and cellular senescence..Semin Cancer Biol2015;30:42-51

[138] Soncini M,Gibelli L,Denegri M.Isolation and characterization of mesenchymal cells from human fetal membranes..J Tissue Eng Regen Med2007;1:296-305

[139] Marconi A,Truzzi F,Pistoni F.Hypoxia-inducible factor-1alpha and CD271 inversely correlate with melanoma invasiveness..Exp Dermatol2015;24:396-8

[140] Beretti F,Longo C,Farnetani F.CD271 is expressed in melanomas with more aggressive behaviour, with correlation of characteristic morphology by in vivo reflectance confocal microscopy..Br J Dermatol2015;172:662-8

[141] Kumar SM,Lu H,Zhang PJ.Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation..Oncogene2012;31:4898-911 PMCID:PMC3343184

[142] Saltari A,Quadri M,Palazzo E.CD271 down-regulation promotes melanoma progression and invasion in three-dimensional models and in zebrafish..J Invest Dermatol2016;136:2049-58

[143] Restivo G,Cheng PF,Bonalli M.Low neurotrophin receptor CD271 regulates phenotype switching in melanoma..Nat Commun2017;8:1988 PMCID:PMC5719420

[144] Strizzi L,Normanno N.Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis..Oncogene2005;24:5731-41

[145] Bianco C,Castro NP,Rollman K.Role of Cripto-1 in stem cell maintenance and malignant progression..Am J Pathol2010;177:532-40 PMCID:PMC2913337

[146] Shukla A,Liu X,Glick AB.Cripto-1 alters keratinocyte differentiation via blockade of transforming growth factor-beta1 signaling: role in skin carcinogenesis..Mol Cancer Res2008;6:509-16

[147] Yan YT,Luo Y,Haltiwanger RS.Dual roles of cripto as a ligand and coreceptor in the nodal signaling pathway..Molecular and Cellular Biology2002;22:4439-49 PMCID:PMC133918

[148] Saeki T,Qi CF,Tahara E.Differential immunohistochemical detection of amphiregulin and cripto in human normal colon and colorectal tumors..Cancer Res1992;52:3467-73

[149] Micalizzi DS,Ford HL.Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression..J Mammary Gland Biol Neoplasia2010;15:117-34 PMCID:PMC2886089

[150] Bianco C,Mancino M,Hamada S.Identification of cripto-1 as a novel serologic marker for breast and colon cancer..Clin Cancer Res2006;12:5158-64

[151] Rangel MC,Castro NP,Cuttitta F.Developmental signaling pathways regulating mammary stem cells and contributing to the etiology of triple-negative breast cancer..Breast Cancer Res Treat2016;156:211-26 PMCID:PMC4819564

[152] Lee KE.From stem cells to cancer stem cells: HIF takes the stage..Curr Opin Cell Biol2012;24:232-5

[153] Bianco C,Lonardo E,Baraty C.Cripto-1 is required for hypoxia to induce cardiac differentiation of mouse embryonic stem cells..Am J Pathol2009;175:2146-58 PMCID:PMC2774077

[154] Hale AJ,den Hertog J.Recent advances in understanding the role of protein-tyrosine phosphatases in development and disease..Dev Biol2017;428:283-92

[155] Yang Z,Qi W,Cui Y.Tenascin-C as a prognostic determinant of colorectal cancer through induction of epithelial-to-mesenchymal transition and proliferation..Exp Mol Pathol2018;105:216-22

[156] Jang TJ,Lee JI.The expression of CD10 and CD15 is progressively increased during colorectal cancer development..Korean J Pathol2013;47:340-7 PMCID:PMC3759633

[157] Pruszak J,Aung MH,Isacson O.Markers and methods for cell sorting of human embryonic stem cell-derived neural cell populations..Stem Cells2007;25:2257-68 PMCID:PMC2238728

[158] Giordano G,Tomaselli E,Parcesepe P.Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer..J Exp Clin Cancer Res2015;34:108 PMCID:PMC4590269

[159] Yaji S,Nakagawa N,Endo T.Major glycan structure underlying expression of the Lewis X epitope in the developing brain is O-mannose-linked glycans on phosphacan/RPTPbeta..Glycobiology2015;25:376-85

[160] Laczmanska I,Gil J,Makowska I.The PTPN13 Y2081D (T>G) (rs989902) polymorphism is associated with an increased risk of sporadic colorectal cancer..Colorectal Dis2017;19:O272-O8

[161] Gupta RA.Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2..Nat Rev Cancer2001;1:11-21

[162] Subbaramaiah K.Cyclooxygenase 2: a molecular target for cancer prevention and treatment..Trends Pharmacol Sci2003;24:96-102

[163] Reddy BS,Lubet R,Kelloff G.Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis..Cancer Res2000;60:293-7

[164] Liu Y,Hu M,Chen S.The role of Cyclooxygenase-2 in colorectal carcinogenesis..Clin Colorectal Cancer2017;16:165-72

[165] Cai J,Huang J,Lin H.Associations between the cyclooxygenase-2 expression in circulating tumor cells and the clinicopathological features of patients with colorectal cancer..J Cell Biochem2018;

[166] Zhang L,Zhang X,Chen S.Arsenic sulfide combined with JQ1, chemotherapy agents, or celecoxib inhibit gastric and colon cancer cell growth..Drug Des Devel Ther2015;9:5851-62 PMCID:PMC4634829

[167] Dixon DA,Bruno A.Mechanistic aspects of COX-2 expression in colorectal neoplasia..Recent Results Cancer Res2013;191:7-37 PMCID:PMC3477597

[168] Wang D.The role of COX-2 in intestinal inflammation and colorectal cancer..Oncogene2010;29:781-8 PMCID:PMC3181054

[169] Hawcroft G,Hull MA.Prostaglandin E2-EP4 receptor signalling promotes tumorigenic behaviour of HT-29 human colorectal cancer cells..Oncogene2007;26:3006-19

[170] Zha S,Nelson WG,De Marzo AM.Cyclooxygenases in cancer: progress and perspective..Cancer Lett2004;215:1-20

[171] Wang D,Sun H,DuBois RN.Prostaglandin E2 promotes colorectal cancer stem cell expansion and metastasis in mice..Gastroenterology2015;149:1884-95.e4 PMCID:PMC4762503

[172] Hanahan D.Hallmarks of cancer: the next generation..Cell2011;144:646-74

[173] Sawaoka H,Tsujii M,Sasaki Y.Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo..Lab Invest1999;79:1469-77

[174] Ghanghas P,Rana C.Chemoprevention of colon cancer through inhibition of angiogenesis and induction of apoptosis by nonsteroidal anti-inflammatory drugs..J Environ Pathol Toxicol Oncol2016;35:273-89

[175] Divvela AKC,Tagaram IK.Pathogenic role of cyclooxygenase-2 in cancer..J Health Sci2010;56:502-16

[176] Xu L.Improving VEGF-targeted therapies through inhibition of COX-2/PGE2 signaling..Mol Cell Oncol2014;1:e969154 PMCID:PMC4905212

[177] Leung WK,Go MY,Chan FK.Cyclooxygenase-2 upregulates vascular endothelial growth factor expression and angiogenesis in human gastric carcinoma..Int J Oncol2003;23:1317-22

[178] Yu HG,Yang YN,Yu JP.Increased abundance of cyclooxygenase-2 correlates with vascular endothelial growth factor-A abundance and tumor angiogenesis in gastric cancer..Cancer Lett2003;195:43-51

[179] Gallo O,Magnelli L,Vannacci A.Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis..Neoplasia2001;3:53-61 PMCID:PMC1505025

[180] Chu J,Trifan OC,Rizzo MT.Potential involvement of the cyclooxygenase-2 pathway in the regulation of tumor-associated angiogenesis and growth in pancreatic cancer..Mol Cancer Ther2003;2:1-7

[181] Yoshida S,Hayashi I,Kamata M.COX-2/VEGF-dependent facilitation of tumor-associated angiogenesis and tumor growth in vivo..Lab Invest2003;83:1385-94

[182] Gately S.Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy..Semin Oncol2004;31:2-11

[183] Gungor H,Eroksuz H.The effectiveness of cyclooxygenase-2 inhibitors and evaluation of angiogenesis in the model of experimental colorectal cancer..Biomed Pharmacother2018;102:221-9

[184] Kurtova AV,Mo Q,Krasnow R.Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance..Nature2015;517:209-13 PMCID:PMC4465385

[185] Pang LY,Argyle DJ.Cyclooxygenase-2: a role in cancer stem cell survival and repopulation of cancer cells during therapy..Stem Cells Int2016;2016:2048731 PMCID:PMC5108861

[186] Liu B,Yan S.Cyclooxygenase-2 promotes tumor growth and suppresses tumor immunity..Cancer Cell Int2015;15:106 PMCID:PMC4635545

[187] Greenhough A,Moore AE,Williams AC.The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment..Carcinogenesis2009;30:377-86

[188] Sobolewski C,Dicato M,Diederich M.The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies..Int J Cell Biol2010;2010:215158 PMCID:PMC2841246

[189] Park GB,Kim D.Sequential treatment with celecoxib and bortezomib enhances the ER stress-mediated autophagy-associated cell death of colon cancer cells..Oncol Lett2018;16:4526-36 PMCID:PMC6126195

[190] Kobayashi K,Murata T.Role of prostaglandins in tumor microenvironment..Cancer Metastasis Rev2018;37:347-54

[191] Wojdasiewicz P,Szukiewicz D.The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis..Mediators Inflamm2014;2014:561459 PMCID:PMC4021678

[192] Zelenay S,Bottcher JP,Rogers N.Cyclooxygenase-dependent tumor growth through evasion of immunity..Cell2015;162:1257-70 PMCID:PMC4597191

[193] Pritchard R,Pacheco-Velazquez SC,Moreno-Sanchez R.Celecoxib inhibits mitochondrial O2 consumption, promoting ROS dependent death of murine and human metastatic cancer cells via the apoptotic signalling pathway..Biochem Pharmacol2018;154:318-34

[194] Ralph SJ,Rodriguez-Enriquez S,Ralph RK.Hitting the Bull’s-Eye in metastatic cancers-NSAIDs elevate ROS in mitochondria, inducing malignant cell death..Pharmaceuticals (Basel)2015;8:62-106 PMCID:PMC4381202

[195] Pacheco-Velazquez SC,Hernandez-Resendiz I,Moreno-Sanchez R.Energy metabolism drugs block triple negative breast metastatic cancer cell phenotype..Mol Pharm2018;15:2151-64

[196] Meng X,Zheng G,Hua T.Doxorubicin combined with celecoxib inhibits tumor growth of medullary thyroid carcinoma in xenografted mice..Oncol Lett2014;7:2053-8 PMCID:PMC4049724

[197] Chen C,Wang CM.Combination of celecoxib and doxorubicin increases growth inhibition and apoptosis in acute myeloid leukemia cells..Leuk Lymphoma2013;54:2517-22

[198] van Wijngaarden J,van Rossum G,Hoekman K.Celecoxib enhances doxorubicin-induced cytotoxicity in MDA-MB231 cells by NF-kappaB-mediated increase of intracellular doxorubicin accumulation..Eur J Cancer2007;43:433-42

[199] Hashitani S,Nishimura N,Takaoka K.Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines..Int J Oncol2003;23:665-72

[200] Chu TH,Hu TH,Ma YL.Celecoxib enhances the therapeutic efficacy of epirubicin for Novikoff hepatoma in rats..Cancer Med2018;7:2567-80 PMCID:PMC6010827

[201] Lin J,Chiu TH.Combination of cyclooxygenase-2 inhibitors and oxaliplatin increases the growth inhibition and death in human colon cancer cells..Biochem Pharmacol2005;70:658-67

[202] Kuhar M,Singh N.Celecoxib enhances the chemotherapeutic response of cisplatin and TNF-alpha in SiHa cells through reactive oxygen species-mediated mitochondrial pathway..Int J Biomed Sci2007;3:176-84 PMCID:PMC3614680

[203] Liu B,Feng J.Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt..Cell Biol Int2008;32:494-501

[204] Kim SH,Song YC.Celecoxib potentiates the anticancer effect of cisplatin on vulvar cancer cells independently of cyclooxygenase..Ann N Y Acad Sci2009;1171:635-41

[205] Li WZ,Li ZG,Ding YQ.Celecoxib enhances the inhibitory effect of cisplatin on Tca8113 cells in human tongue squamous cell carcinoma in vivo and in vitro..J Oral Pathol Med2010;39:579-84

[206] Xu HB,Lv QZ.Celecoxib enhanced the cytotoxic effect of cisplatin in chemo-resistant gastric cancer xenograft mouse models through a cyclooxygenase-2-dependent manner..Eur J Pharmacol2016;776:1-8

[207] Irie T,Tsuji S,Ishii S.Synergistic antitumor effects of celecoxib with 5-fluorouracil depend on IFN-gamma..Int J Cancer2007;121:878-83

[208] Zhao S,Bian H,Zhao F.Synergistic inhibition effect of tumor growth by using celecoxib in combination with oxaliplatin..Cancer Invest2009;27:636-40

[209] Chu TH,Kuo HM,Hu TH.Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN..Oncotarget2014;5:1475-90 PMCID:PMC4039225

[210] Huang C,Liu H,Song X.Celecoxib targets breast cancer stem cells by inhibiting the synthesis of prostaglandin E2 and down-regulating the Wnt pathway activity..Oncotarget2017;8:115254-69 PMCID:PMC5777769

[211] Jin CH,Chen JM,Liu XM.Observation of curative efficacy and prognosis following combination chemotherapy with celecoxib in the treatment of advanced colorectal cancer..J Int Med Res2011;39:2129-40

[212] Debucquoy A,Goethals L,Van Cutsem E.Double blind randomized phase II study with radiation+5-fluorouracil+/-celecoxib for resectable rectal cancer..Radiother Oncol2009;93:273-8

[213] Lin E,Ayers GD.Effect of celecoxib on capecitabine-induced hand-foot syndrome and antitumor activity..Oncology (Williston Park)2002;16:31-7

[214] Lin EH,Crane CC,Skibber J.Retrospective study of capecitabine and celecoxib in metastatic colorectal cancer: potential benefits and COX-2 as the common mediator in pain, toxicities and survival?.Am J Clin Oncol2006;29:232-9

[215] Arber N,Spicak J,Dite P.Celecoxib for the prevention of colorectal adenomatous polyps..N Engl J Med2006;355:885-95

[216] Arber N,Racz I,Breazna A.Five-year analysis of the prevention of colorectal sporadic adenomatous polyps trial..Am J Gastroenterol2011;106:1135-46

[217] Bertagnolli MM,Zauber AG,Breazna A.Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial..Cancer Prev Res (Phila)2009;2:310-21 PMCID:PMC2976587

[218] Mason RP,Day CA.A biological rationale for the cardiotoxic effects of rofecoxib: comparative analysis with other COX-2 selective agents and NSAids..Subcell Biochem2007;42:175-90

[219] Nissen SE,Solomon DH,Libby P.Cardiovascular safety of Celecoxib, Naproxen, or Ibuprofen for arthritis..N Engl J Med2016;375:2519-29